✦ LIBER ✦

Pharmacokinetic Evaluation of Twice-Daily Extended-Release Carbamazepine (CBZ) and Four-Times-Daily Immediate-Release CBZ in Patients with Epilepsy

✍ Scribed by William R. Garnett; Benjamin Levy; Angus M. McLean; Yuxin Zhang; Richard A. Couch; Edward M. Rudnic; John M. Pellock; George W. Belendiuk

Book ID: 109106643
Publisher: Wiley (Blackwell Publishing)
Year: 1998
Tongue: English
Weight: 563 KB
Volume: 39
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1157.1998.tb01372.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steady-state Pharmacokinetics of Lamotri

Steady-state Pharmacokinetics of Lamotrigine when Converting from a Twice-daily Immediate-release to a Once-daily Extended-release Formulation in Subjects with Epilepsy (The COMPASS Study)

✍ Debra J Tompson; Imran Ali; Ruth Oliver-Willwong; Sarah Job; Li Zhu; Francesca L 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 183 KB

Steady-State Pharmacokinetic Comparison

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain

✍ Russell K. Portenoy; Andréa Sciberras; Lise Eliot; Gordon Loewen; Jackie Butler; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 91 KB

(413) Single- and multiple-dose study to

(413) Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability of extended-release oxycodone with sequestered naltrexone (ALO-02) in healthy volunteers: a comparison of ALO-02 40 mg twice daily to OxyContin 40 mg twice daily and ALO-02 80 mg once daily

✍ Gandelman, K.; Lamson, M.; Bramson, C.; Matschke, K.; Salageanu, J.; Malhotra, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 94 KB